This meeting will explore the evidence for intervention with medical hormonal therapy in adolescents with gender dysphoria and the effects of this approach.
The use of gonadotropin-releasing hormone (GnRH) agonists (more commonly known as hormone or puberty blockers) in transgender adolescents is a contentious topic in regards to the ethics of treating children, evidence-based medicine and long term effects.
The early use of blockers has been suggested as reversible but as treatment of this group increases, issues and challenges in regards to fertility preservation and the effects of future gender reassignment surgery, cognitive and bone health have been highlighted.
This area is very controversial, in society and medical practice, with a judicial review ongoing together with a NICE Review of Evidence. In addition, there is a High Court Case challenging the Gillick Competency in adolescents.
This meeting will provide a balanced and informed debate into the current practice affecting medical practitioners from urology, gynaecology, endocrinology and psychiatry.
Topics include:
*Please note we will need to check all GMC numbers of attendees to this meeting. Ensure you bring this with you, attendance may be denied otherwise.
Standard pricing available until 04 May 2021.
| RSM Fellow | RSM Associate | RSM Retired Fellow | RSM Trainee | RSM Student |
|---|---|---|---|---|
| £96.00 | £57.00 | £57.00 | £57.00 | £30.00 |
| Consultant / GP | AHP / Nurse / Midwife | Non Healthcare Professional | Trainee | Student |
|---|---|---|---|---|
| £160.00 | £95.00 | £95.00 | £95.00 | £50.00 |
Mr Michael Dineen, President, Section of Urology
Miss Pippa Sangster, Consultant Urologist and Andrologist, University College London Hospitals NHS Foundation Trust and Mr Roland Morley, Consultant Urologist, Imperial College Healthcare NHS Trust
Professor Dominic Wilkinson, Medical Ethics and Neonatology, University of Oxford
Professor Susan Bewley, Consultant Obstetrician and Gynaecologist
Dr Peter Dunne, Senior Lecturer, University of Bristol Law School
Dr Polly Carmichael, Service Director, The Tavistock and Portman NHS Foundation Trust
Dr Rebecca McLaren, Consultant Psychiatrist, The Tavistock and Portman NHS Foundation Trust
Professor Christina Richards, Lead Clinical Psychologist, The Tavistock and Portman NHS Foundation Trust
Professor Neil Evans, Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow
Professor Gary Butler, Paediatric Endocrinology, University College London Hospitals NHS Foundation Trust
Dr Peter Hammond. Consultant Endocrinologist, Harrogate and District NHS Foundation Trust
Chair: Mr Michael Dineen, President, Section of Urology
Miss Melanie Davies, Consultant Gynaecologist, Chair of Fertility Preservation UK, British Fertility Society
Miss Ephia Yasmin, Consultant Gynaecologist, University College London Hospitals NHS Foundation Trust
Miss Pippa Sangster
Mr Suks Minhas, Consultant Urologist and Andrologist, Imperial College Healthcare NHS Trust
Mr Nim Christopher, Consultant Urologist and Andrologist, University College London Hospitals NHS Foundation Trust
Chairs: Mr Phil Thomas, Consultant Urologist and Genitourinary Reconstructive Surgeon, Nuffield Hospital Brighton and Mr James Bellringer, Consultant Urologist and Genitourinary Reconstructive Surgeon, Parkside Hospital)
For: Miss Tina Rashid, Consultant Urologist and Genitourinary Reconstructive Surgeon, Imperial College Healthcare NHS Trust
Against: Mr Mark-Bram Bouman, Plastic Reconstructive Gender Surgeon, VU University Medical Center Amsterdam
Chaired by Mr Roland Morley
Professor Gary Butler, Dr Polly Carmichael, Miss Pippa Sangster, Miss Melanie Davies, Professor Susan Bewley
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
